Docket Room.
SB 1640·AZ·senate

marijuana; qualifying illnesses; testing; complaints

FailedFiled Feb 9, 2026
Sponsor: Kevin Payne (R)
Latest Action

Senate: Second reading

Feb 10, 2026

Email me when SB 1640 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 1640. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill updates Arizona's medical‑marijuana program by defining how much patients and caregivers may possess, limiting registration fees, creating a dedicated fund, and requiring detailed product labeling. It also establishes a grant program for clinical trials and mandates third‑party testing and public complaint handling. The measures would affect patients, caregivers, nonprofit dispensaries, labs and researchers, but the bill failed to pass.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 1640

3 free questions a day, no account

History

  1. Senate Second Reading
  2. Senate First Reading

Sponsors

  • Kevin Payne (R) · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 1640 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 1640 free

Or ask your AI assistant about SB 1640 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice